| Dr Benjamin Lewis Wright, MD | |
|
13400 E Shea Blvd, Scottsdale, AZ 85259 | |
| (480) 301-8000 | |
| Not Available |
| Full Name | Dr Benjamin Lewis Wright |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 15 Years |
| Location | 13400 E Shea Blvd, Scottsdale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750515268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 50429 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic - Arizona | 7012829930 | 1395 |
News Archive
"Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights," Inter Press Service reports.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
NPS MedicineWise is reminding health professionals that while various media reports have recently linked statins to a variety of adverse events and questioned their efficacy, these drugs remain one of the most effective strategies for reducing the risk of cardiovascular disease (CVD).
Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor.
› Verified 8 days ago
| Entity Name | Mayo Clinic Arizona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558332494 PECOS PAC ID: 7012829930 Enrollment ID: O20031105000782 |
News Archive
"Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights," Inter Press Service reports.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
NPS MedicineWise is reminding health professionals that while various media reports have recently linked statins to a variety of adverse events and questioned their efficacy, these drugs remain one of the most effective strategies for reducing the risk of cardiovascular disease (CVD).
Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor.
› Verified 8 days ago
| Entity Name | Phoenix Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922112044 PECOS PAC ID: 0446278584 Enrollment ID: O20051107000704 |
News Archive
"Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights," Inter Press Service reports.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
NPS MedicineWise is reminding health professionals that while various media reports have recently linked statins to a variety of adverse events and questioned their efficacy, these drugs remain one of the most effective strategies for reducing the risk of cardiovascular disease (CVD).
Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin Lewis Wright, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 | Dr Benjamin Lewis Wright, MD 13400 E Shea Blvd, Scottsdale, AZ 85259 Ph: (480) 301-8000 |
News Archive
"Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights," Inter Press Service reports.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
NPS MedicineWise is reminding health professionals that while various media reports have recently linked statins to a variety of adverse events and questioned their efficacy, these drugs remain one of the most effective strategies for reducing the risk of cardiovascular disease (CVD).
Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor.
› Verified 8 days ago
Hugh L. Mackechnie, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 7514 E Monterey Way, Suite 1, Scottsdale, AZ 85251 Phone: 480-949-7377 Fax: 480-949-8339 | |
Jean Audrey Nelson, FNP-C Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7514 E Monterey Way, Suite 1, Scottsdale, AZ 85251 Phone: 480-949-7377 Fax: 480-949-8339 | |
Dr. Stuart Z Lanson, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8406 E Shea Blvd, #100, Scottsdale, AZ 85260 Phone: 480-994-9512 Fax: 480-994-3773 | |
Linda Alvarez-thull, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10250 N 92nd St, #114, Scottsdale, AZ 85258 Phone: 480-661-6184 Fax: 480-661-6971 | |
Dr. Jodi Leah Rubin, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9097 E Desert Cove Ave Ste 250, Scottsdale, AZ 85260 Phone: 480-614-0499 Fax: 480-614-4344 | |
Michael Everett Manning, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7514 E Monterey Way, Suite 1, Scottsdale, AZ 85251 Phone: 480-949-7377 Fax: 480-949-8339 | |
Rachael Marie Stillwagon, P.A. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10200 N 92nd St Ste 130, Scottsdale, AZ 85258 Phone: 480-614-8011 Fax: 480-614-8014 |